In the Middle East and Africa pharmaceutical industry, there were 16 M&A deals announced in Q3 2024, worth a total value of $1.8bn, according to GlobalData’s Deals Database. The $1.7bn acquisition of V-Wave by Johnson & Johnson was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2024 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, M&A activity in Middle East and Africa increased by 15285% in Q3 2024 compared with the previous quarter’s total of $11.7m and rose by 1163% as compared to Q3 2023. Related deal volume increased by 167% in Q3 2024 versus the previous quarter and was 78% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in Middle East and Africa in 9M 2024 were Bank AlJazira; A.G.P./Alliance Global Partners; Cohen with 2, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Middle East and Africa in 9M 2024 were Meitar Law Offices; Fenwick & West; Goodwin Procter with 3, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.